Cellomatics Biosciences Ltd

PamGene is a functional proteomics Company with a unique 3D array platform to measure the ACTIVITY of Tyrosine and Serine/Threonine kinase.

We offer Products (described in our Showcase pages, PamStation-12 ®, Pamchip arrays ® and Reagent kits) and Services (lead optimization, translational/ preclinical research and biomarker discovery). We have developed powerful software tools (BioNavigator) for complex data analysis with which you can interpret results in a biological context. We support clinical trials in the oncology area.

Pamgene is advancing research in Oncology as well as other areas (Neurobiology, Immunology, Metabolic disorders, cardiovascular respiratory diseases). Our technology has a wide range of Applications from fundamental and discovery research to clinical development of therapeutic and diagnostic biomarkers.

Our patented technology stands out in allowing scientists in industry and academia to measure enzyme activity within a cellular context and fully decorated proteins. The assays have high sensitivity, broad kinome coverage and works for many sample sources.

PamGene has a strong science foundation and the number of publications applying our technology continues to rise. PamGene's Customer Service team supports your research with dedication. The PamAcademy offers advanced training, from workflows to data analysis, interpretation and storage. PamGene's PamCloud space allows User-interaction and furthers knowledge exploration.

Please visit our web site for further information (https://www.pamgene.com/) and get in touch with us! (https://www.pamgene.com/en/landing.htm)

Taros Chemicals GmbH & Co. KG, an independent, privately owned contract research organization based in Dortmund, Germany, has been serving the chemistry needs of pharmaceutical, chemical and biotech companies since its inception in 1999. A forerunner in the early German biotech scene, Taros can claim more than 13,000 syntheses, research and process chemistry projects delivered to-date to an increasingly expanding and diverse base of global customers.

In its state-of-the-art facilities in Dortmund's prestigious BioMedizinZentrum (BMZ), the hub of top ranking biotech organizations, Taros'​ team of highly creative and skilled scientists, aided by its state-of-the-art laboratory facilities, are wholly committed to solving a wide range of customers'​ R&D problems in innovative drug discovery, medicinal chemistry and classical synthetic chemistry. Their collective knowledge and experience in industrial organic chemistry, span a period of over 160 years, and in active drug discovery, around 60 years, covering the full spectrum, from big pharma to biotechnology. Taros is active today in therapeutic areas which include oncology, respiratory, CNS, cardiovascular, inflammation, pain, metabolism and infectious diseases, in all small-molecule target classes.

Our company's mission is to enhance the quality of human lives by providing advanced and innovative chemistry-driven technologies to our customers R&D endeavors in the global marketplace. We strive hard to provide creative, holistic and cost-effective solutions with the highest level of quality, reliability and integrity. We continuously endorse loyalty and commitment in our employees, inspiring them to provide exceptional value to our customers'​ R&D processes, by anticipating hurdles before they arise, by foreseeing potential cost and lead time reductions, and most importantly, by facilitating their competitive and "early to market"​ advantage.

We are a global healthcare intelligence partner, consistently ranked among the top CROs and best employers worldwide.
We help develop life-saving and life-improving drugs with our comprehensive clinical development services, including data management, statistical analysis, clinical trial management, medical writing, and regulatory and drug development consulting.

Qualitis Ltd, is a Full-Service Clinical Research and Medical Consulting Organization based in Greece and offering a comprehensive portfolio of clinical development and medical consulting services to the Pharmaceutical, Biotechnology and Medical Device industries.

Through a commitment to a Company culture of superior quality service, integrity and innovation, Qualitis focuses on exceeding its customers particular needs and expectations.

Qualitis Team possesses an in-depth and long-term experience and expertise in both clinical research and medical-marketing environment and is strongly dedicated in constant learning and continuous improvement driven to create added value for our customers and become an integral part of their business success.

With a strong focus on people and standards, Qualitis has built upon the 3 milestones of business success: Quality, Commitment and Customer Trust.

Our specialty areas include but are not limited to the following:
-Cardiovascular diseases
-Neurology & Psychiatry
-Pulmonary/Respiratory
-Genitourinary
-Gastroenterology
-Oncology
-Orthopedics
-Pediatrics
-Biotechnology
-Allergy/Immunology
-Dermatology
-Virology
-Endocrinology
-Hematology
-Ophthalmology

Areas of Operation-Projects Portfolio:
-Phase II-IV Clinical Trials
-Medical Device Studies
-Non-Interventional Studies
-Pharmacovigilance Studies
-IIS (Investigator Initiated Studies)
-Epidemiological Studies
-Market Surveys

Customers Profile:
-Pharmaceutical Companies
-Biotechnology Companies
-Medical Devices Companies
-Academic Research Institutes & Hospitals
-International CROs

Contact Details: E-mail: info@qualitis.gr
Telephone: +30 210-7797750
Fax: +30 210-7470441

Cerba Research is the merge of Barc Lab, Histalim and Cerba Xpert. All 3 entities are part of the Cerba HealthCare group and have decided to join forces under one name.

Cerba Research provides the highest quality specialized laboratory and diagnostic solutions while leveraging patient data and scientific insight to shape and advance clinical trials. With our global footprint and access to leading regional labs, data, patients, technology, and partnered resources, we support global biotech, pharma, and IVD organizations to improve the lives of patients around the world.

From the translation of preclinical to clinical, through commercialization, our expert scientists collaborate with you to optimize your therapeutic development and obtain critical insights earlier. We help accelerate your therapies through the development of highly specialized custom assays, deep biomarker expertise, and a passion for scientific innovation across complex therapeutic areas. Our global network of leading, specialty laboratories ensures you have access to quality data and can reach your patients. Together, we’ll improve patients’ lives around the globe.